Influence of psychiatric diagnoses on interferon-α treatment for chronic hepatitis C in a veteran population

American Journal of Gastroenterology

Volumn 96, Issue 1, 2001, Pages 157-164

  Ho, Samuel B ^a,b   Nguyen, Huy ^a   Tetrick, Lori L ^a   Opitz, Greg A ^a   Basara, Michael L ^a   Dieperink, Eric ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG INDUCED DISEASE; FEMALE; HEPATITIS C; HUMAN; MALE; MENTAL DISEASE; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; TREATMENT OUTCOME; VIRUS HEPATITIS;

ADULT; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; MIDDLE AGED; PROBABILITY; PSYCHOTIC DISORDERS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VETERANS;

EID: 0035135915     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02261-9     Document Type: Article

References (26)

1. Epidemiology of hepatitis C
2. Quality forum on Hepatitis C virus
3. Hepatitis C. Standards for provider evaluation and testing
4. Epidemiology of hepatitis C among veterans with alcoholic liver disease
5. Under Secretary for Health, U.S
6. Health status of Vietnam veterans. 1. Psychosocial characteristics
7. War syndromes and their evaluation: From the U.S. Civil War to the Persian Gulf War
8. Therapy of hepatitis C: Metaanalysis of interferon alfa-2b trials
9. Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: A randomized multicenter trial
10. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C. Effects of dose and duration
11. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
12. Randomized trial of interferon alpha 2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alfa 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
13. Side effects of alpha interferon in chronic hepatitis C
14. Psychiatric complications of long-term interferon alfa therapy
15. Suicide associated with alfa-interferon therapy for chronic viral hepatitis
16. Interferons as mediators of psychiatric morbidity: An investigation in a trial of recombinant alpha-interferon in hepatitis-B carders
17. A survey of adverse events in the 11,241 patients with chronic viral hepatitis treated with alpha interferon
18. Chronic hepatitis: An update on terminology and reporting
19. Improved sustained response following treatment of chronic hepatitis C by gradual reduction in the interferon dose
20. Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay
21. Construction of recombinant RNA template for use as internal standards in quantitative RT-PCR
22. Interferon treatment of hepatitis C associated with symptoms of PTSD
23. Treatment with interferon-alpha in patients with chronic hepatitis and mood or anxiety disorders
24. Interferon alpha can be used successfully in patients with hepatitis C positive chronic hepatitis who have a psychiatric illness
25. Treatment of chronic hepatitis C in individuals with pre-existing or confounding neuropsychiatric disease